Australia markets closed

BioCardia, Inc. (BCDA)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.4100-0.2800 (-7.59%)
At close: 04:00PM EDT
3.3700 -0.04 (-1.17%)
After hours: 07:12PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 6.22M
Enterprise value 6.50M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)10.89
Price/book (mrq)10.67
Enterprise value/revenue 13.90
Enterprise value/EBITDA -3.16

Trading information

Stock price history

Beta (5Y monthly) 1.41
52-week change 3-90.87%
S&P500 52-week change 323.76%
52-week high 343.8000
52-week low 33.2000
50-day moving average 35.2954
200-day moving average 36.9766

Share statistics

Avg vol (3-month) 3124.65k
Avg vol (10-day) 3722.96k
Shares outstanding 51.82M
Implied shares outstanding 61.83M
Float 81.21M
% held by insiders 129.48%
% held by institutions 17.13%
Shares short (15 May 2024) 415.7k
Short ratio (15 May 2024) 41.65
Short % of float (15 May 2024) 41.00%
Short % of shares outstanding (15 May 2024) 40.86%
Shares short (prior month 15 Apr 2024) 418.08k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 306 June 2019
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 330 May 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-4,136.36%

Management effectiveness

Return on assets (ttm)-132.67%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)468k
Revenue per share (ttm)0.31
Quarterly revenue growth (yoy)-14.10%
Gross profit (ttm)N/A
EBITDA -10.33M
Net income avi to common (ttm)-10.34M
Diluted EPS (ttm)-7.0500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)949k
Total cash per share (mrq)0.52
Total debt (mrq)1.23M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.31
Book value per share (mrq)-1.27

Cash flow statement

Operating cash flow (ttm)-8.94M
Levered free cash flow (ttm)-5.3M